ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,032.38
0.56%
US Tech 100
20,389.60
0.88%
Dow Jones
44,910.65
0.42%
Brent Oil
71.98
-0.08%
Bitcoin
96,787.79
-0.72%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Boundless Bio Inc (BOLD)

  7. Boundless Bio Inc (BOLD) News

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BOLD
DateTimeSourceHeadlineSymbolCompany
11/25/20247:00AMGlobeNewswire Inc.Boundless Bio to Participate in the Piper Sandler Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
11/07/20244:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
11/07/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
11/07/20244:01PMGlobeNewswire Inc.Boundless Bio Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:BOLDBoundless Bio Inc
11/05/20247:00AMGlobeNewswire Inc.Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
10/15/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
10/14/20248:00AMGlobeNewswire Inc.Boundless Bio Announces Departure of Chief Financial OfficerNASDAQ:BOLDBoundless Bio Inc
09/11/20247:00AMGlobeNewswire Inc.Boundless Bio to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
08/20/20247:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BOLDBoundless Bio Inc
08/20/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
08/12/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
08/12/20244:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
08/12/20244:01PMGlobeNewswire Inc.Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial ResultsNASDAQ:BOLDBoundless Bio Inc
06/05/20247:00AMBusiness WireBoundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
05/13/20247:06AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
05/13/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
05/13/20247:00AMBusiness WireBoundless Bio Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:BOLDBoundless Bio Inc
05/06/20248:00AMBusiness WireBoundless Bio to Present at the Citizens JMP Life Sciences Conference 2024NASDAQ:BOLDBoundless Bio Inc
04/11/20248:00AMBusiness WireBoundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene AmplificationsNASDAQ:BOLDBoundless Bio Inc
04/08/20248:00AMBusiness WireBoundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024NASDAQ:BOLDBoundless Bio Inc
02/14/20205:23PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
02/14/20204:35PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
02/14/20204:15PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
02/11/20204:41PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
02/05/202011:27AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
01/27/20209:38AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:BOLDBoundless Bio Inc
01/21/20206:00AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
01/21/20206:00AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
12/03/20197:13PMPR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc.NASDAQ:BOLDBoundless Bio Inc
12/02/20196:01PMBusiness WireAstellas Enters into Definitive Agreement to Acquire Audentes TherapeuticsNASDAQ:BOLDBoundless Bio Inc
 Showing the most relevant articles for your search:NASDAQ:BOLD

Your Recent History

USOTC
WDLF
Decentral Life (PK)
AMEX
KULR
KULR Technology
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
IQST
iQSTEL (QX)
USOTC
RNVA
Rennova Health (CE)
USOTC
ERHE
ERHC Energy (CE)
USOTC
QSEP
QS Energy (PK)
NYSE
IONQ
IonQ
NASDAQ
FCEL
FuelCell Energy
NASDAQ
SMCI
Super Micro Computer
USOTC
BIEL
Bioelectronics (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
COIN
XRPUSD
Ripple
USOTC
ASII
Accredited Solutions (PK)
USOTC
HIRU
Hiru (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Ultimate Trader

1 year 30%, 2 years 40% and *3 years 40%

*Across 3 years $3395.52 only $1697.76